Diverse Biotech Chooses Doylestown, Pennsylvania For U.S. Headquarters
11/20/2019
A prominent incubator for small growing life sciences companies, the Pennsylvania Biotechnology Center contains a wealth of resources and a core support group of scientists and executives motivated to work collaboratively with their commercial colleagues on common research themes.
Diverse Biotech said its focus is on discovering and developing novel therapeutics, utilizing cannabidiol as a core component and combining it through advanced conjugate chemistry with other targeted medicines to develop new chemical entities that are theoretically more efficacious and less toxic. Our initial focus is on hard-to-treat oncologic disorders including basal cell carcinoma and other Dermatology related cancers, Pancreatic cancer and Glioblastoma, where targeted therapies have proven largely unsuccessful thus far and there is significant unmet need.
According to company officials, in addition, Diverse Biotech continues to identify and evaluate additional locations to relocate its Miami Laboratory facilities.
"We are very happy with our strategic decision to establish our headquarters at the Pennsylvania Biotechnology Center, it is truly a tremendous scientific community and a perfect place for Diverse Biotech to continue its growth journey," said Stella Vnook, Diverse Biotech's CEO.
Project Announcements
Jel Sert Company Expands West Chicago, Illinois, Manufacturing Operations
06/16/2025
Technomics Expands Arlington County, Virginia, Operations
06/16/2025
Conveyor Technology Expands North Little Rock, Arkansas, Manufacturing Operations
06/16/2025
Amazon Plans Salem Township-Falls Township, Pennsylvania, Operations
06/16/2025
Sentio BioSciences Expands Maryland Heights, Missouri, Production Operations
06/14/2025
Titan Mechanical Plans Defiance, Ohio, Fabrication Operations
06/12/2025
Most Read
-
First Person: Joe Capes, CEO, LiquidStack
Q2 2025
-
The Legal Limits of DEI in Incentives Agreements, Hiring, and Contracting
Q2 2025
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Navigating the new era of SCIF construction
Q1 2025
-
Rethinking Life Sciences Site Selection in a Resilient and Dynamic Market
Q2 2025
-
Get Your Mega Site ‘Project Ready’
Q2 2025